Search tips
Search criteria 


Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1985 July; 52(1): 87–92.
PMCID: PMC1977175

Failure of systemic ketosis to control cachexia and the growth rate of the Walker 256 carcinosarcoma in rats.


The Walker 256 carcinosarcoma was shown to lack the enzyme 3-ketoacid CoA transferase. This suggests that ketone bodies cannot be used as a major substrate for the energy metabolism of this tumour. Systemic ketosis (1-2 mM acetoacetate plus 3-hydroxybutyrate) was induced both in tumour-bearing and in non-tumour-bearing rats with a diet containing 70% medium chain triglyceride. However, in rats bearing the Walker 256 tumour, this dietary ketosis did not reduce the tumour growth rate nor did it prevent the subsequent decrease in host body weight. Host body nitrogen losses were similarly unaffected. The ketosis induced in tumour bearing rats was shown to be abnormal since the blood glucose concentration of ketotic, tumour-bearing rats was significantly higher compared with that of ketotic non-tumour bearing rats (5.2 +/- 0.4 mM cf 3.4 +/- 0.6 mM, P less than 0.01). These results may partly explain why systemic ketosis failed to alter the growth and cachexia induced by the Walker 256 carcinosarcoma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1013K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BALL HA, WICK AN, SANDERS C. Influence of glucose antimetabolites on the Walker tumor. Cancer Res. 1957 Apr;17(3):235–239. [PubMed]
  • Binkiewicz A, Sadeghi-Najad A, Hochman H, Loridan L, Senior B. An effect of ketones on the concentrations of glucose and of free fatty acids in man independent of the release of insulin. J Pediatr. 1974 Feb;84(2):226–231. [PubMed]
  • Brennan MF. Uncomplicated starvation versus cancer cachexia. Cancer Res. 1977 Jul;37(7 Pt 2):2359–2364. [PubMed]
  • Brennan MF. Total parenteral nutrition in the cancer patient. N Engl J Med. 1981 Aug 13;305(7):375–382. [PubMed]
  • Cederbaum AI, Rubin E. Fatty acid oxidation, substrate shuttles, and activity of the citric acid cycle in hepatocellular carcinomas of varying differentiation. Cancer Res. 1976 Sep;36(9 PT1):2980–2987. [PubMed]
  • Conyers RA, Need AG, Durbridge T, Harvey ND, Potezny N, Rofe AM. Cancer, ketosis and parenteral nutrition. Med J Aust. 1979 May 5;1(9):398–399. [PubMed]
  • Demetrakopoulos GE, Brennan MF. Tumoricidal potential of nutritional manipulations. Cancer Res. 1982;42(2 Suppl):756s–765s. [PubMed]
  • Gold J. Inhibition of Walker 256 intramuscular carcinoma in rats by administration of hydrazine sulfate. Oncology. 1971;25(1):66–71. [PubMed]
  • Holroyde CP, Gabuzda TG, Putnam RC, Paul P, Reichard GA. Altered glucose metabolism in metastatic carcinoma. Cancer Res. 1975 Dec;35(12):3710–3714. [PubMed]
  • Magee BA, Potezny N, Rofe AM, Conyers RA. The inhibition of malignant cell growth by ketone bodies. Aust J Exp Biol Med Sci. 1979 Oct;57(5):529–539. [PubMed]
  • Nixon DW, Heymsfield SB, Cohen AE, Kutner MH, Ansley J, Lawson DH, Rudman D. Protein-calorie undernutrition in hospitalized cancer patients. Am J Med. 1980 May;68(5):683–690. [PubMed]
  • Nixon DW, Lawson DH, Kutner M, Ansley J, Schwarz M, Heymsfield S, Chawla R, Cartwright TH, Rudman D. Hyperalimentation of the cancer patient with protein-calorie undernutrition. Cancer Res. 1981 Jun;41(6):2038–2045. [PubMed]
  • Pedersen PL. Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res. 1978;22:190–274. [PubMed]
  • Phinney SD, Bistrian BR, Wolfe RR, Blackburn GL. The human metabolic response to chronic ketosis without caloric restriction: physical and biochemical adaptation. Metabolism. 1983 Aug;32(8):757–768. [PubMed]
  • Preston T, Reeds PJ, East BW, Holmes PH. A comparison of body protein determination in rats by in vivo neutron activation and carcass analysis. Clin Sci (Lond) 1985 Mar;68(3):349–355. [PubMed]
  • Radcliffe AG, Wolfe RR, Colpoys MF, Muhlbacher F, Wilmore DW. Ketone-glucose interaction in fed, fasted, and fasted-infected sheep. Am J Physiol. 1983 May;244(5):R667–R675. [PubMed]
  • Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev. 1980 Jan;60(1):143–187. [PubMed]
  • Sherwin RS, Hendler RG, Felig P. Effect of ketone infusions on amino acid and nitrogen metabolism in man. J Clin Invest. 1975 Jun;55(6):1382–1390. [PMC free article] [PubMed]
  • Tisdale MJ, Brennan RA. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. Br J Cancer. 1983 Feb;47(2):293–297. [PMC free article] [PubMed]
  • Tisdale MJ. Role of acetoacetyl-CoA synthetase in acetoacetate utilization by tumor cells. Cancer Biochem Biophys. 1984 Jun;7(2):101–107. [PubMed]
  • Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res. 1979 Jun;39(6 Pt 1):1968–1972. [PubMed]
  • Williamson DH, Bates MW, Page MA, Krebs HA. Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem J. 1971 Jan;121(1):41–47. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK